Literature DB >> 26893760

A modified method for the culture of naturally HPV-infected high-grade cervical intraepithelial neoplasia keratinocytes from human neoplastic cervical biopsies.

Yu-Zhen Liu1, Tian-Tian Wang1, You-Zhong Zhang2.   

Abstract

Few studies on cervical intraepithelial neoplasia (CIN) keratinocyte cultures are available due to the numerous technical and methodological problems associated with the in vitro cultivation of these cells. The present study investigated an applicable and effective method for the in vitro cultivation of high-grade CIN keratinocytes from human neoplastic cervical biopsies. Human neoplastic cervical tissue sections were obtained and digested using type I collagen in order to dissociate the cells. The cells were seeded in tissue culture plastic plates that were coated with rat tail collagen type I and contained modified keratinocyte serum-free medium (K-SFM) supplemented with 5% fetal bovine serum. The medium was replaced with K-SFM on days 3, 5 and 7, respectively. The unattached cells were recovered and the cell viability was determined accurately using the Trypan Blue exclusion method. The expression of keratin 14 (K14), keratin 19 (K19), keratin 17 (K17) and P63 was assayed using immunofluorescence in order to identify the presence of CIN keratinocytes. The present results indicated that the attachment rate of CIN keratinocytes significantly increased between 56.75±1.76% on day 3 and 77.09±3.55% on day 5, and became relatively stable between days 5 and 7. The cell viability significantly decreased between 83.00±0.50% on day 5 and 68.17±1.04% on day 7. The passaged CIN keratinocytes maintained the original unequally sized, abnormally shaped morphology and did not undergo differentiation. In addition, the passaged CIN keratinocytes exhibited the same human papilloma virus (HPV) genotype that was detected in the original primary cells. K14 and K19 were expressed in the majority of the normal and CIN keratinocytes, whereas K17 and P63 were expressed only in high-grade CIN keratinocytes. The present study proposes a simple and practical method for rapidly obtaining highly purified naturally HPV-infected high-grade CIN keratinocytes from small neoplastic cervical tissues, and provides an appropriate first medium change time for the primary culture of CIN keratinocytes.

Entities:  

Keywords:  cell attachment; cell viability; cervical intraepithelial neoplasia; epithelial cells; keratinocyte; primary cell culture

Year:  2016        PMID: 26893760      PMCID: PMC4734280          DOI: 10.3892/ol.2016.4096

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  19 in total

1.  Improved amplification of genital human papillomaviruses.

Authors:  P E Gravitt; C L Peyton; T Q Alessi; C M Wheeler; F Coutlée; A Hildesheim; M H Schiffman; D R Scott; R J Apple
Journal:  J Clin Microbiol       Date:  2000-01       Impact factor: 5.948

2.  Establishment of a novel method for primary culture of normal human cervical keratinocytes.

Authors:  Yu-Zhen Liu; Xiu-Ping Lü; Zi-Xuan Pan; Wei Zhang; Zhao-Ri Chen; Hui Wang; Hua Liu; You-Zhong Zhang
Journal:  Chin Med J (Engl)       Date:  2013       Impact factor: 2.628

3.  Human papillomavirus is a necessary cause of invasive cervical cancer worldwide.

Authors:  J M Walboomers; M V Jacobs; M M Manos; F X Bosch; J A Kummer; K V Shah; P J Snijders; J Peto; C J Meijer; N Muñoz
Journal:  J Pathol       Date:  1999-09       Impact factor: 7.996

4.  Comparison of trypan blue dye exclusion and fluorometric assays for mammalian cell viability determinations.

Authors:  S A Altman; L Randers; G Rao
Journal:  Biotechnol Prog       Date:  1993 Nov-Dec

5.  Expression of the p53 homologue p63 in early cervical neoplasia.

Authors:  B J Quade; A Yang; Y Wang; D Sun; J Park; E E Sheets; A Cviko; J M Federschneider; R Peters; F D McKeon; C P Crum
Journal:  Gynecol Oncol       Date:  2001-01       Impact factor: 5.482

Review 6.  Human papillomavirus and cervical cancer.

Authors:  Mark Schiffman; Philip E Castle; Jose Jeronimo; Ana C Rodriguez; Sholom Wacholder
Journal:  Lancet       Date:  2007-09-08       Impact factor: 79.321

7.  Culture of keratinocytes for transplantation without the need of feeder layer cells.

Authors:  Neeltje A Coolen; Michelle Verkerk; Linda Reijnen; Marcel Vlig; Antoon J van den Bogaerdt; Melanie Breetveld; Susan Gibbs; Esther Middelkoop; Magda M W Ulrich
Journal:  Cell Transplant       Date:  2007       Impact factor: 4.064

8.  Natural history of cervical neoplasia and risk of invasive cancer in women with cervical intraepithelial neoplasia 3: a retrospective cohort study.

Authors:  Margaret R E McCredie; Katrina J Sharples; Charlotte Paul; Judith Baranyai; Gabriele Medley; Ronald W Jones; David C G Skegg
Journal:  Lancet Oncol       Date:  2008-04-11       Impact factor: 41.316

Review 9.  Coordinate expression of cytokeratin 8 and cytokeratin 17 immunohistochemical staining in cervical intraepithelial neoplasia and cervical squamous cell carcinoma: an immunohistochemical analysis and review of the literature.

Authors:  Katsuhide Ikeda; Genshu Tate; Takao Suzuki; Toshiyuki Mitsuya
Journal:  Gynecol Oncol       Date:  2008-01-14       Impact factor: 5.482

Review 10.  Synthetic viruses: a new opportunity to understand and prevent viral disease.

Authors:  Eckard Wimmer; Steffen Mueller; Terrence M Tumpey; Jeffery K Taubenberger
Journal:  Nat Biotechnol       Date:  2009-12       Impact factor: 54.908

View more
  2 in total

1.  Isolation of Biopsy-Derived, Human Cervical Keratinocytes Propagated as Monolayer and Organoid Cultures.

Authors:  Peter L Villa; Robert Jackson; Statton Eade; Nicholas Escott; Ingeborg Zehbe
Journal:  Sci Rep       Date:  2018-12-14       Impact factor: 4.379

Review 2.  In Vitro Organotypic Systems to Model Tumor Microenvironment in Human Papillomavirus (HPV)-Related Cancers.

Authors:  Vincenza De Gregorio; Francesco Urciuolo; Paolo Antonio Netti; Giorgia Imparato
Journal:  Cancers (Basel)       Date:  2020-05-03       Impact factor: 6.639

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.